Application Nr Approved Date Route Status External Links
ANDA074514 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Carefully Consider The Potential Benefits And Risks Of Diclofenac Sodium Delayed-Release Tablets, Usp And Other Treatment Options Before Deciding To Use Diclofenac Sodium Delayed-Release Tablets, Usp. Use The Lowest Effective Dose For The Shortest Duration Consistent With Individual Patient Treatment Goals (See Warnings). Diclofenac Sodium Delayed-Release Tablets Are Indicated: For Relief Of The Signs And Symptoms Of Osteoarthritis For Relief Of The Signs And Symptoms Of Rheumatoid Arthritis For Acute Or Long-Term Use In The Relief Of Signs And Symptoms Of Ankylosing Spondylitis

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Diclofenac Sodium DICLOFENAC SODIUM ZINC1281

Comments